Cord Blood Safety Study

POSTED ON 9/2/2010 IN Research BY Christopher Centeno

Congrats to Beike and Medistem for a well done safety study on expanded cord blood treatments in China for neurological disorders. Again, compared to the safety profile of common sledgehammer immune supressant drugs for conditions like Multiple Sclerosis., this therapy seems to be much safer.  While a bigger dataset followed for longer periods would be nice, this paper seems to support the safety profile already published by our group and others showing that cell based therapy complications are generally less than the more traditional therapies they help replace.

  1. healthcare
  2. industry articles

comments powered by Disqus

Search Blog